L. Nicod

Discipline

Sciences de l'information et de la communication (2) Gestion et management (2) Economies et finances (2) Sociologie (1) Science politique (1) Psychologie (1) Anthropologie biologique (1)

Type de document

Articles (24) Recensions (8) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Patients (9) Patients (9) Treatment (8) Human beings (8) Diagnosis (7) Lungs (7) Diagnosis (7) thérapie (6) Diseases (6) Tuberculosis (6) Therapeutics (6) Tuberculosis (6) temps (durée) (5) infection (5) maladie (5) Time (5) Management (5) Infection (5) Diseases (5) Management (5) Analysis (5) maladie (5) gestion (4) analyse (4) adulte (4) survie (4) Control (4) Survival (4) Mycobacterium tuberculosis (4) Older people (4)

Documents écrit par L. Nicod (25) | parle de L. Nicod (0)

Correction to: Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
S. Andenmatten et al.
Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
C. Pison et al.
The impact of price variance characteristics on perceived price fairness: The moderating effect of economic benefit
Vu H. et al. (19 mai 2021)
Parésies et paralysies diaphragmatiques [Diaphragmatic paralysis and paresis : review]
A. Baskaralingam et al. (9 sept. 2020)
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
S. Laurent et al.
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA
L. Klimek et al. (2020)
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
L. Klimek et al. (2020)
Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie
L. Klimek et al. (2020)
Multicenter analysis of sputum microbiota in tuberculosis patients.
C. Sala et al. (2020)
Outils informatiques pour la prise en charge du nodule pulmonaire isolé - Détectabilité et prédiction de malignité [Computer instruments for the management of isolated pulmonary nodule. Detectability and prediction of malignancy]
P. Vremaroiu et al. (13 nov. 2019)
Nouveautés concernant l’asthme en médecine de premier recours [What's new on asthma in primary care]
B. Touilloux et al. (13 nov. 2019)
Et si la BPCO disparaissait…
L. Nicod (13 nov. 2019)
Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
S. Andenmatten et al.
Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities.
F. Zakham et al.
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
O. Opota et al.
MR Volumetry of Lung Nodules: A Pilot Study.
J. Delacoste et al. (2019)
Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.
M. Bernasconi et al.
Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
V. Rozot et al. (2015)
Maladies liées à l'altitude et consultation de médecine de montagne
A. Lovis et al. (2012)
Alliance for biomedical research in Europe.
U. Smith et al. (2011)
H1N1: chances et opportunités [H1N1: chances and opportunities]
L. Nicod et al. (18 nov. 2009)
Epidemiology of pulmonary hypertension: new data from the Swiss registry.
C. Tueller et al. (28 juin 2008)
Pulmonary hypertension in Switzerland: treatment and clinical course.
M. Fischler et al. (28 juin 2008)
Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy.
C. Beglinger et al. (3 nov. 2007)
Severe pulmonary hypertension: data from the Swiss Registry.
H. Stricker et al. (16 juin 2001)